Home
Conditions
Pancreatic Neoplasms

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

2,460 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Completed

Oral Microbiome and Pancreatic Cancer

NCT03302637

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: New York University School of Medicine New York, United States

View Trial Details

Completed

Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection

NCT00584363

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

Diagnostic Yield of 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic Lesions

NCT02920944

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +5 more
Locations: The Catholic University of Korea Seoul, No State, South Korea

View Trial Details

Completed

Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

NCT02241187

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer

NCT02017015

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +5 more
Locations: 307 Hospital of Chinese PLA Beijing, China

Peking Union Medical College Hospital Beijing, China

Chinese PLA General Hospital Beijing, China

Beijing Cancer Hospital Beijing, PR, China

View all 15 locations

View Trial Details

Completed

Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining

NCT02486497

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea

View Trial Details

Completed

Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery

NCT00900016

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Proton Radiation for Resectable Carcinoma of the Pancreas

NCT00763516

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: University of Florida Proton Therapy Institute Jacksonville, Florida, United States

View Trial Details

Completed

Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer

NCT01553019

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: University of Florida Proton Therapy Institute Jacksonville, Florida, United States

Provision Proton Therapy Center Knoxville, Tennessee, United States

View Trial Details

Completed

Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer

NCT01150630

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Istituto Scientifico H. San Raffaele Milan, Italy

View Trial Details

Pancreatic Neoplasms

Pancreatic Neoplasms trial results

Related conditions